The development of improved vaccines against tuberculosis (TB) is directly linked to the investigation of new and better correlates of protection after vaccination against TB. Cloning and characterization of bovine homologues of the antimicrobial protein granulysin (Bo-lysin) and perforin by our group could be used as potential biomarkers for TB vaccination efficacy. In the present study, we examined the kinetics of granulysin, perforin, IFNgamma and Fas-L responses to Mycobacterium bovis purified protein derivative (PPD) stimulation by peripheral blood mononuclear cells from M. bovisDeltaRD1-, BCG- and non-vaccinated cattle. Gene expression profiles following PPD stimulation showed significant increases in transcripts for granulysin and IFNgamma in both CD4(+) and CD8(+) T cells in BCG-vaccinated as compared with non-vaccinated animals. Perforin and IFNgamma examined by flow cytometry, showed a difference of 1-2% more PPD-specific cells in BCG-vaccinated than non-vaccinated animals. In the vaccine trial, granulysin and perforin were significantly increased in both vaccine groups as compared with control after vaccination and challenge. IFNgamma expression was increased only after vaccination and secretion was higher in the control, non-protected group as compared with both vaccine groups demonstrating no correlation with protection upon vaccination. In summary, results shown here provide evidence that granulysin and perforin are prospective candidates as biomarkers of protection after vaccination against TB.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1865-1682.2008.01058.x | DOI Listing |
Infect Immun
December 2024
Institute for Medical Microbiology and Hygiene, University Hospital Ulm, Ulm, Germany.
Protection against infections with intracellular bacteria requires the interaction of macrophages and T-lymphocytes, including CD8 T cells. Recently, the expression of natural killer cell receptors NKG2A and NKG2C was introduced as markers of CD8 T-cell subsets. The goal of this study was to functionally characterize human NKG2A and NKG2C-expressing T cells using the major pathogen () as a model organism.
View Article and Find Full Text PDFImmunol Invest
November 2024
Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Cells
October 2024
Molecular Immunology-Institute for Immunology, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.
Background: Although belonging to different branches of the immune system, cytotoxic CD8 αβ T cells and γδ T cells utilize common cytolytic effectors including FasL, granzymes, perforin and granulysin. The effector proteins are stored in different subsets of lysosome-related effector vesicles (LREVs) and released to the immunological synapse upon target cell encounter. Notably, in activated cells, LREVs and potentially other vesicles are continuously produced and released as extracellular vesicles (EVs).
View Article and Find Full Text PDFNat Commun
October 2024
Institute for Immunology and Infectious Diseases, Murdoch University, Perth, Australia.
Diagnostics (Basel)
September 2024
Department of Pediatric Rheumatology, Hacettepe University, 06230 Ankara, Turkey.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!